Results 61 to 70 of about 69,467 (236)
Cross-Border Patent Disputes: Unified Patent Court or International Commercial Arbitration?
Utrecht Journal of International and European Law, 2016 Currently, the enforcement of a patent that is registered in several countries involves the risk of getting different and conflicting decisions from the national courts.
Ana Alba Betancourt
doaj +1 more source
Molecular Oncology, EarlyView.Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Molecular Oncology, EarlyView.RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Nano is nano is nano or: nanotechnology – a European legal perspective
Nanotechnology Reviews, 2014 In Europe, nanotechnology is perceived as one of the innovative technologies that may drive technological progress. At the same time, Europe historically has followed an approach to cautiously but proactively regulate new technologies, instead of taking ...
Fulda Christian +2 more
doaj +1 more source
The reflection of the struggle of Russian companies for promising markets in the patent statistics
Ekonomika Nauki, 2017 The article analyzes data from the annual report of the European patent agency, reflecting the struggle of industrialized countries for the EU market in the projection of the patent landscape of 2016.
N. G. Kurakova
doaj +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Molecular Oncology, EarlyView.The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Patenting of technologies related to renewable energy: the case of biodiesel
Revista Tecnologia, 2010 In this work a study of technological tendencies in biodiesel was carried out, based on information extracted of patent documents. The term “patent document” covers published patent applications or granted patents.
Márcia França Fernandes dos Santos +2 more
doaj
Unitary Patent and the Unified Patent Court: Attractive for SMEs?
Croatian Yearbook of European Law and PolicyThe Unitary Patent Package (UPP) was conceived as a means of simplifying and centralising patent protection and enforcement across participating EU Member States. The introduction of a supranational patent jurisdiction and a unitary protection system was
Ivana Božac
doaj +1 more source
Journal of Technology Management & Innovation, 2013 The present article aims to assess the innovative activity in the Brazilian most representative sector in biotechnology field. The search was conducted through patent applications of residents at the National Institute of Industrial Property (INPI ...
Liliana Machado Mendes +2 more
doaj +1 more source